Hepatitis B immune globulin

Source: Wikipedia, the free encyclopedia.
Hepatitis B immune globulin
Clinical data
Trade namesHepaGam B, Nabi-HB, Zutectra, others
AHFS/Drugs.comMonograph
Pregnancy
category
Routes of
administration
Intramuscular injection, intravenous
ATC code
Legal status
Legal status
Identifiers
DrugBank
ChemSpider
  • none
UNII
ChEMBL
 ☒NcheckY (what is this?)  (verify)

Hepatitis B immunoglobulin (HBIG) is a human

immunoglobulin that is used to prevent the development of hepatitis B[2] and is used for the treatment of acute exposure to HBsAg.[3][4][5]

Medical uses

HBIG is indicated as a

]

HBIG is given by either intramuscular (IM) or intravenous (IV) route, depending on the

HBIG.[7] As with all blood-derived products, the transmission of prions is possible as a residual risk.[8]

Concomitant vaccination

HBIG should be given within 14 days of exposure to the hepatitis B virus.

hepatitis B vaccination is initiated at the time of the initial HBIG administration, thus providing long term protection.[9]

HBIG is classified as

]

Preparation

HBIG is prepared from the

Brand names

See also

References

  1. ^ "Hepatitis b immune globulin Use During Pregnancy". Drugs.com. 3 August 2020. Retrieved 13 September 2020.
  2. S2CID 41095427
    .
  3. ^ "HepaGam B (hepatitis b immune globulin intravenous- human injection". DailyMed. U.S. National Library of Medicine. 15 January 2019. Retrieved 14 July 2020.
  4. ^ a b "HepaGam B- human hepatitis b virus immune globulin injection". DailyMed. U.S. National Library of Medicine. 16 April 2020. Retrieved 14 July 2020.
  5. ^ a b "Nabi-HB (hepatitis b immune globulin- human liquid". DailyMed. U.S. National Library of Medicine. 22 July 2019. Retrieved 14 July 2020.
  6. ^ "Hepatitis B Immune Globulin (Intramuscular Route, Intravenous Route)". Mayo Clinic. Retrieved 3 June 2009.
  7. ^ a b Poinier AC, Romito K, Thompson EG, Flamm SL, eds. (11 November 2010). "Hepatitis B Immunoglobulin (HBIG)". BlueShield information. Archived from the original on 21 July 2011. Retrieved 3 June 2009.
  8. S2CID 25966682
    .
  9. .
  10. ^ "Hepatitis B Immune Globulin (Human) Product description with dose schedule" (PDF). Bayer Corporation. March 2004. Archived from the original (PDF) on 11 May 2008. Retrieved 3 June 2009.
  11. ^ "HepaGam B". U.S. Food and Drug Administration (FDA). 4 April 2017. Retrieved 14 July 2020.
  12. ^ "HyperHEP B S/D (hepatitis b immune globulin- human injection". DailyMed. U.S. National Library of Medicine. 22 January 2020. Retrieved 14 July 2020.
  13. ^ "Nabi-HB". U.S. Food and Drug Administration (FDA). 4 April 2017. Retrieved 14 July 2020.
  14. ^ "Zutectra EPAR". European Medicines Agency. 17 September 2018. Retrieved 14 July 2020.

External links